ALLAKOS INC's ticker is ALLK and the CUSIP is 01671P100. A total of 118 filers reported holding ALLAKOS INC in Q1 2020. The put-call ratio across all filers is 0.87 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $238 | -99.6% | 105 | -99.2% | 0.00% | – |
| Q2 2023 | $56,544 | -2.0% | 12,969 | 0.0% | 0.00% | – |
| Q1 2023 | $57,712 | -31.3% | 12,969 | -51.8% | 0.00% | – |
| Q2 2022 | $84,000 | -45.1% | 26,900 | 0.0% | 0.00% | – |
| Q1 2022 | $153,000 | +77.9% | 26,900 | +200.1% | 0.00% | – |
| Q4 2021 | $86,000 | -91.6% | 8,963 | -7.4% | 0.00% | -100.0% |
| Q3 2021 | $1,022,000 | +4.7% | 9,676 | -15.5% | 0.00% | 0.0% |
| Q2 2021 | $976,000 | -52.8% | 11,447 | -36.5% | 0.00% | -50.0% |
| Q1 2021 | $2,067,000 | -37.2% | 18,013 | -23.4% | 0.00% | -42.9% |
| Q4 2020 | $3,291,000 | +94.5% | 23,507 | +13.0% | 0.01% | +75.0% |
| Q3 2020 | $1,692,000 | +1232.3% | 20,798 | +1074.4% | 0.00% | – |
| Q2 2020 | $127,000 | +122.8% | 1,771 | +37.3% | 0.00% | – |
| Q1 2020 | $57,000 | – | 1,290 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Samsara BioCapital, LLC | 270,965 | $12,055,000 | 6.94% |
| NEA Management Company, LLC | 2,268,188 | $100,912,000 | 5.27% |
| Fairmount Funds Management LLC | 178,662 | $7,949,000 | 4.82% |
| Redmile Group, LLC | 2,976,928 | $132,444,000 | 3.71% |
| Boxer Capital, LLC | 675,000 | $30,031,000 | 2.05% |
| Rock Springs Capital Management LP | 235,000 | $10,455,000 | 0.43% |
| Cormorant Asset Management, LP | 200,000 | $8,898,000 | 0.41% |
| RAMIUS ADVISORS LLC | 31,155 | $1,386,000 | 0.35% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 15,700 | $692,000 | 0.32% |
| Handelsinvest Investeringsforvaltning | 20,000 | $890,000 | 0.24% |